Top compounds associated with response to RP11-249L12.1

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	myricetin	CTRPv2	pan-cancer	AAC	0.033	0.4
mRNA	BRD-A02303741:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.031	0.4
mRNA	BRD-K29313308	CTRPv2	pan-cancer	AAC	0.032	0.4
mRNA	BIX-01294	CTRPv2	pan-cancer	AAC	0.03	0.4
mRNA	BRD-A71883111	CTRPv2	pan-cancer	AAC	0.032	0.4
mRNA	BRD-K27188169:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.044	0.4
mRNA	selumetinib:JQ-1 (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.029	0.4
mRNA	cabozantinib	CTRPv2	pan-cancer	AAC	0.031	0.4
mRNA	PRL-3 Inhibitor I	CTRPv2	pan-cancer	AAC	0.032	0.4
mRNA	rigosertib	CTRPv2	pan-cancer	AAC	0.028	0.4

Download CSV